Lord, Abbett & Co. LLC Simulations Plus, Inc. Transaction History

Lord, Abbett & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$38.45 - $55.66 $1.8 Million - $2.6 Million	-46,718 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$49.67 - $68.96 $4.14 Million - $5.75 Million	-83,351 Reduced 64.08%	46,718 $2.57 Million
Q1 2021 May 11, 2021	BUY	$60.06 - $89.52 $914,173 - $1.36 Million	15,221 Added 13.25%	130,069 $8.23 Million
Q4 2020 Feb 09, 2021	BUY	$53.26 - $77.18 $1.29 Million - $1.87 Million	24,181 Added 26.67%	114,848 $8.26 Million
Q3 2020 Nov 12, 2020	BUY	$57.51 - $75.36 $1.81 Million - $2.37 Million	31,474 Added 53.17%	90,667 $6.83 Million
Q2 2020 Aug 14, 2020	BUY	$32.91 - $59.82 $1.95 Million - $3.54 Million	59,193 New	59,193 $3.54 Million

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $582M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.